The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010


Poster Presenter

Unique Plant Extracts Derived From The Greek Flora As Potent Pharmaceutical Agents For The Treatment Of Osteoporosis
Kalpoutzakis E, Polychronopoulos P, Makropoulou M, Bourgiezi I, Aligiannis N, Tenta R
Greece

Background: The flowery aerial parts of Greek species of the genus Sideritis (Labiatae) are used for the preparation of 'Mountain tea'. A previous study showed that Sideritis euboea stimulates osteoblastic cells and suppresses breast cancer cells without exhibiting proliferative effects on the uterus. MG-63 cells are human osteoblast-like osteosarcoma cells, widely used for the pharmacological evaluation of compounds which target bone metabolism.

Methods: Sideritis clandestina subsp. clandestine, Sideritis clandestina subsp. peloponnesiaca and Cichorium spinosum were collected in Peloponnesos and Crete. The air-dried plant materials were powdered, extracted with appropriate solvents and concentrated to crude extracts. MG-63 cells were treated with these plant extracts and the inhibition of cell proliferation was evaluated by the MTT assay. A compound that is already being tested for osteoporosis treatment served as a positive control.

Results: The plant extracts tested inhibited MG-63 cell proliferation in a dose-dependent manner after 96 of treatment. Sideritis MeOH as well as Cichorium MeOH extract were even more efficient in inhibiting cell proliferation than the positive control.

Conclusions: Herein, we show that unique plant extracts derived from the Greek flora strongly inhibit osteoblasts proliferation. Our data are very promising, regarding the application of these extracts in the field of osteoporosis.


















[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy